interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Drospirenone; Estetrol

Generic competition · all medicines · read 12 November 2026

Is there a generic of Drospirenone; Estetrol, and who makes it?

Drospirenone; Estetrol appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Drospirenone; Estetrol1 dosage-form group in the Orange Book
0generic makers listed
  1. Drospirenone; Estetrol appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Nextstellis. No generic is listed as marketed.

20202025203020352040204501brand 2021data datePatent 7732430 listed to expire 15 January 2028Patent 12427114 listed to expire 17 June 2036Patent 11957694 listed to expire 17 June 2036Patent 11793760 listed to expire 17 June 2036Patent 11964055 listed to expire 17 June 2036Patent 12233074 listed to expire 9 February 2043Patent 12458649 listed to expire 1 October 2043
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 15 January 2028Patent 7732430 drug product
  • 17 June 2036Patent 12427114 drug product
  • 17 June 2036Patent 11957694 drug product
  • 17 June 2036Patent 11793760 drug product
  • 17 June 2036Patent 11964055 drug product
  • 9 February 2043Patent 12233074 drug product
  • 1 October 2043Patent 12458649

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.